Bayer and Salus Optima partner on AI-enabled healthy aging journey
- Details
- Category: Bayer

Pfizer announces topline Phase 2b results of oral GLP-1R agonist, danuglipron, in adults with obesity
- Details
- Category: Pfizer

Bayer and Hurdle launch precision health strategic partnership
- Details
- Category: Bayer

Bayer invests 130 million EUR in new production facility for innovative parenteral products
- Details
- Category: Bayer

Pfizer and Astellas' XTANDI® approved by U.S. FDA in earlier prostate cancer treatment setting
- Details
- Category: Pfizer

Roche's subcutaneous injection of Tecentriq recommended by the EU's CHMP for multiple cancer types
- Details
- Category: Roche

Bayer and Recursion focus research collaboration on oncology
- Details
- Category: Bayer

The oncology-focused collaboration will leverage Bayer's small molecule compound library and expertise in biology and medicinal chemistry as well as Recursion’s purpose-built artificial intelligence-guided drug discovery platform.
More Pharma News ...
- Bayer expands global life science incubator network
- Bayer and Broad Institute of MIT and Harvard extend research collaboration to develop new cancer therapies
- AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
- Pfizer and BioNTech announce positive topline data for mRNA-based combination vaccine program against influenza and COVID-19
- Roche enters into a definitive agreement to acquire Telavant including rights to novel TL1A directed antibody (RVT-3101) for the treatment of inflammatory bowel disease from Roivant
- AskBio contribution to advancing gene therapy highlighted at ESGCT 30th Congress
- FDA approves PENBRAYA™, the first and only vaccine for the prevention of the five most common serogroups causing meningococcal disease in adolescents